Recruiting Idiopathic Thrombocytopenic Purpura Studies in New Haven
About Idiopathic Thrombocytopenic Purpura Clinical Trials in New Haven
Immune thrombocytopenia (ITP) is an autoimmune condition where the immune system destroys platelets, leading to easy bruising and bleeding. It can occur in children (often self-limiting) or adults (often chronic). Treatment includes corticosteroids, thrombopoietin receptor agonists, and rituximab.
There are currently 3 idiopathic thrombocytopenic purpura clinical trials recruiting participants in New Haven, CT. These studies are seeking a combined 289 participants. Research is being sponsored by Novartis Pharmaceuticals, argenx, Incyte Corporation. Clinical trial participation is free and participants receive study-related medical care at no cost.
Idiopathic Thrombocytopenic Purpura Clinical Trials in New Haven — FAQ
Are there idiopathic thrombocytopenic purpura clinical trials in New Haven?
Yes, there are 3 idiopathic thrombocytopenic purpura clinical trials currently recruiting in New Haven, CT. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New Haven?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Haven research site will contact you about next steps.
Are clinical trials in New Haven free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Haven studies also compensate for your time and travel.
What idiopathic thrombocytopenic purpura treatments are being tested?
The 3 active trials in New Haven are testing new therapies including novel drugs, biologics, and treatment approaches for idiopathic thrombocytopenic purpura.
Data updated October 15, 2026 from ClinicalTrials.gov